Underdosing of common antibiotics for obese patients in the ED

American Journal of Emergency Medicine

Volumn 30, Issue 7, 2012, Pages 1212-1214

  Roe, Jada L ^a   Fuentes, Joseph M ^a   Mullins, Michael E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CIPROFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BODY MASS; CONTROLLED STUDY; CYSTIC FIBROSIS; DATA ANALYSIS; DRUG TREATMENT FAILURE; DRUG UNDERDOSE; EMERGENCY CARE; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEBRILE NEUTROPENIA; HUMAN; INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL RECORD; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 84865530200     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2011.05.027     Document Type: Article

References (18)

1. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
2. M.E. Falagas, and M. Kompoti Obesity and infection Lancet Infect Dis 6 2006 438 446
3. M.E. Falagas, A.P. Athanasoulia, G. Peppas, and D.E. Karageorgopoulos Effect of body mass index on the outcome of infections: a systematic review Obes Rev 10 2009 280 289
4. C.E. Edmiston, C. Krepel, and H. Kelly Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels? Surgery 136 2004 738 747
5. R.A. Forse, B. Karam, L.D. MacLean, and N.V. Christou Antibiotic prophylaxis for surgery in morbidly obese patients Surgery 106 1989 750 757
6. D.T. Bearden, and K.A. Rodvold Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics Clin Pharmacokinet 38 2000 415 426
7. D.R. Abernethy, and D.J. Greenblatt Drug disposition in obese humans: an update Clin Pharmacokinet 11 1986 199 213
8. D.J. Morgan, and K.M. Bray Lean body mass as a predictor of drug dosage. Implications for drug therapy Clin Pharmacokinet 26 1994 292 307
9. S. Janmahasatian, S.B. Duffull, S. Ash, L.C. Ward, N.M. Byrne, and B. Green Quantification of lean bodyweight Clin Pharmacokinet 44 2005 1051 1065
10. R.J. Bosma, J.A. Krikken, J.J. Homan van der Heide, P.E. de Jong, and G.J. Navis Obesity and renal hemodynamics Contrib Nephrol 151 2006 184 202
11. D.J. Rea, J.K. Heimback, and J.P. Grande Glomerular volume and renal histology in obese and non-obese living kidney donors Kidney Int 70 2006 1636 1641
12. R.A. Blouin, and G.W. Warren Pharmacokinetic considerations in obesity J Pharm Sci 88 1999 1 7
13. M.P. Pai, and D.T. Bearden Antimicrobial dosing considerations in obese adult patients: insights from the Society of Infectious Diseases Pharmacists Pharmacotherapy 27 8 2007 1081 1091
14. K. Chiba, M. Tsuchiya, J. Kato, K. Ochi, Z. Kawa, and T. Ishizaki Cefotiam disposition in markedly obese athlete patients, Japanese sumo wrestlers Antimicrob Agents Chemother 33 1989 1188 1192
15. R.L. Yost, and H. Derendorf Disposition of cefotaxime and its deacetyl metabolite in morbidly obese male and female subjects Ther Drug Monit 8 1986 189 194
16. S. Allard, M. Kinzig, and G. Bovin Intravenous ciprofloxacin disposition in obesity Clin Pharmacol Ther 54 1993 368 373
17. U.M. Hollenstein, M. Brunner, R. Schmid, and M. Muller Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing Int J Obes Relat Metab Disord 25 2001 354 358
18. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377